These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 6093274)
1. Acyclovir in cytomegalovirus infection 3 1/2 years after renal transplantation. An unusual case and dramatic response. Barnett PS; Meyers AM; Schoub BD; Johnson S; Botha JR S Afr Med J; 1984 Oct; 66(17):635-7. PubMed ID: 6093274 [TBL] [Abstract][Full Text] [Related]
14. Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk renal allograft recipients. Carrieri G; Jordan ML; Shapiro R; Scantlebury VP; Vivas C; Kusne S; Magnone M; McCauley J; Starzl TE Transplant Proc; 1995 Feb; 27(1):961-3. PubMed ID: 7879246 [No Abstract] [Full Text] [Related]
15. A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients. Pavlopoulou ID; Syriopoulou VP; Chelioti H; Daikos GL; Stamatiades D; Kostakis A; Boletis JN Clin Microbiol Infect; 2005 Sep; 11(9):736-43. PubMed ID: 16104989 [TBL] [Abstract][Full Text] [Related]
16. Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection. Razeghi E; Hadadi A; Mansor-Kiaei M; Molavi M; Khashayar P; Pourmand G Transplant Proc; 2007 May; 39(4):993-6. PubMed ID: 17524872 [TBL] [Abstract][Full Text] [Related]
17. Successful treatment with ganciclovir of disseminated cytomegalovirus infection after liver transplantation. Stein DS; Verano AS; Levandowski RA Am J Gastroenterol; 1988 Jun; 83(6):684-6. PubMed ID: 2837082 [TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. Balfour HH; Chace BA; Stapleton JT; Simmons RL; Fryd DS N Engl J Med; 1989 May; 320(21):1381-7. PubMed ID: 2541335 [TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection in kidney transplant recipients: Evolution of approach through three eras. Boucher A; Lord H; Collette S; Morin M; Dandavino R Transplant Proc; 2006 Dec; 38(10):3506-8. PubMed ID: 17175316 [TBL] [Abstract][Full Text] [Related]
20. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection. Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]